Invasion of vaginal epithelial cells by uropathogenic Escherichia coli.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
04 06 2020
Historique:
received: 13 07 2019
accepted: 13 05 2020
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 19 8 2020
Statut: epublish

Résumé

Host-associated reservoirs account for the majority of recurrent and oftentimes recalcitrant infections. Previous studies established that uropathogenic E. coli - the primary cause of urinary tract infections (UTIs) - can adhere to vaginal epithelial cells preceding UTI. Here, we demonstrate that diverse urinary E. coli isolates not only adhere to, but also invade vaginal cells. Intracellular colonization of the vaginal epithelium is detected in acute and chronic murine UTI models indicating the ability of E. coli to reside in the vagina following UTI. Conversely, in a vaginal colonization model, E. coli are detected inside vaginal cells and the urinary tract, indicating that vaginal colonization can seed the bladder. More critically, bacteria are identified inside vaginal cells from clinical samples from women with a history of recurrent UTI. These findings suggest that E. coli can establish a vaginal intracellular reservoir, where it may reside safely from extracellular stressors prior to causing an ascending infection.

Identifiants

pubmed: 32499566
doi: 10.1038/s41467-020-16627-5
pii: 10.1038/s41467-020-16627-5
pmc: PMC7272400
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2803

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI112541
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI107052
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK103910
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007347
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007569
Pays : United States

Références

Mysorekar, I. U. & Hultgren, S. J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl Acad. Sci. USA 103, 14170–14175 (2006).
pubmed: 16968784 doi: 10.1073/pnas.0602136103
Forde, B. M. et al. Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection. Nat. Commun. 10, 3643 (2019).
pubmed: 31409795 pmcid: 6692316 doi: 10.1038/s41467-019-11571-5
Chen, S. L. et al. Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci. Transl. Med. 5, 184ra160 (2013).
doi: 10.1126/scitranslmed.3005497
Gratrix, J. et al. Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin. Infect. Dis. 60, 398–404 (2015).
pubmed: 25336625 doi: 10.1093/cid/ciu831
Surewaard, B. G. et al. Identification and treatment of the Staphylococcus aureus reservoir in vivo. J. Exp. Med. 213, 1141–1151 (2016).
pubmed: 27325887 pmcid: 4925027 doi: 10.1084/jem.20160334
Dillon, H. C., Gray, E., Pass, M. A. & Gray, B. M. Anorectal and vaginal carriage of group B streptococci during pregnancy. J. Infect. Dis. 145, 794–799 (1982).
pubmed: 7045248 doi: 10.1093/infdis/145.6.794
Lidwell, O. M. et al. Nasal acquisition of Staphylococcus aureus in a subdivided and mechanically ventilated ward: endemic prevalence of a single staphylococcal strain. J. Hyg. 68, 417–433 (1970).
pubmed: 5272345 doi: 10.1017/S0022172400042327
Armed Forces Health Surveillance, C. Urinary tract infections, active component, U.S. Armed Forces, 2000–2013. MSMR 21, 7–11 (2014). comment, 11–12.
Gupta, K. & Stamm, W. E. Pathogenesis and management of recurrent urinary tract infections in women. World J. Urol. 17, 415–420 (1999).
pubmed: 10654373 doi: 10.1007/s003450050168
Russo, T. A., Stapleton, A., Wenderoth, S., Hooton, T. M. & Stamm, W. E. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J. Infect. Dis. 172, 440–445 (1995).
pubmed: 7622887 doi: 10.1093/infdis/172.2.440
Chen, Z. et al. The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection. Int. Urogynecol. J. 29, 1775–1782 (2018).
pubmed: 29946828 pmcid: 6244753 doi: 10.1007/s00192-018-3679-2
Luo, Y. et al. Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection. J. Clin. Microbiol. 50, 4002–4007 (2012).
pubmed: 23035197 pmcid: 3502954 doi: 10.1128/JCM.02086-12
Silverman, J. A., Schreiber, H. L. T., Hooton, T. M. & Hultgren, S. J. From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr. Urol. Rep. 14, 448–456 (2013).
pubmed: 23832844 pmcid: 3797163 doi: 10.1007/s11934-013-0354-5
Aabenhus, R., Hansen, M. P., Siersma, V. & Bjerrum, L. Clinical indications for antibiotic use in Danish general practice: results from a nationwide electronic prescription database. Scand. J. Prim. Health Care 35, 162–169 (2017).
pubmed: 28585886 pmcid: 5499316 doi: 10.1080/02813432.2017.1333321
Shapiro, D. J., Hicks, L. A., Pavia, A. T. & Hersh, A. L. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. J. Antimicrob. Chemother. 69, 234–240 (2014).
pubmed: 23887867 doi: 10.1093/jac/dkt301
CDC. CDC, U.S. Department of Health and Human Services, Atlanta, GA, 2019.
Spaulding, C. N. et al. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature 546, 528–532 (2017).
pubmed: 28614296 pmcid: 5654549 doi: 10.1038/nature22972
Schilling, J. D., Lorenz, R. G. & Hultgren, S. J. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect. Immun. 70, 7042–7049 (2002).
pubmed: 12438384 pmcid: 132990 doi: 10.1128/IAI.70.12.7042-7049.2002
Kunin, C. M., Polyak, F. & Postel, E. Periurethral bacterial flora in women. Prolonged intermittent colonization with Escherichia coli. JAMA 243, 134–139 (1980).
pubmed: 6985678 doi: 10.1001/jama.1980.03300280032024
Schaeffer, A. J., Jones, J. M. & Dunn, J. K. Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N. Engl. J. Med. 304, 1062–1066 (1981).
pubmed: 7010174 doi: 10.1056/NEJM198104303041802
Venegas, M. F. et al. Binding of type 1-piliated Escherichia coli to vaginal mucus. Infect. Immun. 63, 416–422 (1995).
pubmed: 7822005 pmcid: 173011 doi: 10.1128/IAI.63.2.416-422.1995
Klumpp, D. J. et al. Epithelial differentiation promotes the adherence of type 1-piliated Escherichia coli to human vaginal cells. J. Infect. Dis. 186, 1631–1638 (2002).
pubmed: 12447740 doi: 10.1086/345557
Krohn, M. A., Thwin, S. S., Rabe, L. K., Brown, Z. & Hillier, S. L. Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. J. Infect. Dis. 175, 606–610 (1997).
pubmed: 9041332 doi: 10.1093/infdis/175.3.606
Hillier, S. L., Krohn, M. A., Rabe, L. K., Klebanoff, S. J. & Eschenbach, D. A. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin. Infect. Dis. 16(Suppl. 4), S273–S281 (1993).
pubmed: 8324131 doi: 10.1093/clinids/16.Supplement_4.S273
Martinez, J. J., Mulvey, M. A., Schilling, J. D., Pinkner, J. S. & Hultgren, S. J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19, 2803–2812 (2000).
pubmed: 10856226 pmcid: 203355 doi: 10.1093/emboj/19.12.2803
Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497 (1998).
pubmed: 9822381 doi: 10.1126/science.282.5393.1494
Ulett, G. C. et al. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect. Immun. 75, 3233–3244 (2007).
pubmed: 17420234 pmcid: 1932929 doi: 10.1128/IAI.01952-06
Spurbeck, R. R. et al. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect. Immun. 79, 4753–4763 (2011).
pubmed: 21911462 pmcid: 3232662 doi: 10.1128/IAI.05621-11
Justice, S. S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl Acad. Sci. USA 101, 1333–1338 (2004).
pubmed: 14739341 doi: 10.1073/pnas.0308125100
Thongsomboon, W. et al. Phosphoethanolamine cellulose: a naturally produced chemically modified cellulose. Science 359, 334–338 (2018).
pubmed: 29348238 doi: 10.1126/science.aao4096
Scherf, H. & Köllermann, M. W. [The periurethral flora in female patients with recurrent urinary tract infection (UTI) (author’s transl)]. Monatsschr. Kinderheilkd. 125, 787–790 (1977).
pubmed: 333275
Brumfitt, W., Gargan, R. A. & Hamilton-Miller, J. M. Periurethral enterobacterial carriage preceding urinary infection. Lancet 1, 824–826 (1987).
pubmed: 2882232 doi: 10.1016/S0140-6736(87)91606-0
Pabich, W. L. et al. Prevalence and determinants of vaginal flora alterations in postmenopausal women. J. Infect. Dis. 188, 1054–1058 (2003).
pubmed: 14513427 doi: 10.1086/378203
Stamey, T. A., Timothy, M., Millar, M. & Mihara, G. Recurrent urinary infections in adult women. The role of introital enterobacteria. Calif. Med. 115, 1–19 (1971).
pubmed: 5105794 pmcid: 1517922
Fichorova, R. N., Desai, P. J., Gibson, F. C. 3rd & Genco, C. A. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect. Immun. 69, 5840–5848 (2001).
pubmed: 11500462 pmcid: 98702 doi: 10.1128/IAI.69.9.5840-5848.2001
Kinlock, B. L., Wang, Y., Turner, T. M., Wang, C. & Liu, B. Transcytosis of HIV-1 through vaginal epithelial cells is dependent on trafficking to the endocytic recycling pathway. PLoS ONE 9, e96760 (2014).
pubmed: 24830293 pmcid: 4022679 doi: 10.1371/journal.pone.0096760
Jain, A. et al. Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception. Hum. Reprod. 29, 242–252 (2014).
pubmed: 24291662 doi: 10.1093/humrep/det423
Marrs, C. N. et al. Evidence for Gardnerella vaginalis uptake and internalization by squamous vaginal epithelial cells: implications for the pathogenesis of bacterial vaginosis. Microbes Infect. 14, 500–508 (2012).
pubmed: 22227318 doi: 10.1016/j.micinf.2011.12.009
Shabayek, S. & Spellerberg, B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front. Microbiol. 9, 437 (2018).
pubmed: 29593684 pmcid: 5861770 doi: 10.3389/fmicb.2018.00437
Subashchandrabose, S., Hazen, T. H., Rasko, D. A. & Mobley, H. L. Draft genome sequences of five recent human uropathogenic Escherichia coli isolates. Pathog. Dis. 69, 66–70 (2013).
pubmed: 23821517 pmcid: 3843978
Rasko, D. A. et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J. Bacteriol. 190, 6881–6893 (2008).
pubmed: 18676672 pmcid: 2566221 doi: 10.1128/JB.00619-08
Eberly, A. R. et al. Biofilm formation by uropathogenic Escherichia coli is favored under oxygen conditions that mimic the bladder environment. Int. J. Mol. Sci. 18, 2077 (2017).
pmcid: 5666759 doi: 10.3390/ijms18102077
O’Brien, V. P., Dorsey, D. A., Hannan, T. J. & Hultgren, S. J. Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner. PLoS Pathog. 14, e1007457 (2018).
pubmed: 30543708 pmcid: 6292575 doi: 10.1371/journal.ppat.1007457
Garofalo, C. K. et al. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect. Immun. 75, 52–60 (2007).
pubmed: 17074856 doi: 10.1128/IAI.01123-06
Eto, D. S., Sundsbak, J. L. & Mulvey, M. A. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell. Microbiol. 8, 704–717 (2006).
pubmed: 16548895 doi: 10.1111/j.1462-5822.2006.00691.x
Eto, D. S., Jones, T. A., Sundsbak, J. L. & Mulvey, M. A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 3, e100 (2007).
pubmed: 17630833 pmcid: 1914067 doi: 10.1371/journal.ppat.0030100
Cossart, P. & Sansonetti, P. J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304, 242–248 (2004).
pubmed: 15073367 doi: 10.1126/science.1090124
Casella, J. F., Flanagan, M. D. & Lin, S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature 293, 302–305 (1981).
pubmed: 7196996 doi: 10.1038/293302a0
Dhakal, B. K. & Mulvey, M. A. Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. J. Biol. Chem. 284, 446–454 (2009).
pubmed: 18996840 pmcid: 2610520 doi: 10.1074/jbc.M805010200
da Silva, C. V. et al. A glance at Listeria and Salmonella cell invasion: different strategies to promote host actin polymerization. Int. J. Med. Microbiol. 302, 19–32 (2012).
pubmed: 21783413 doi: 10.1016/j.ijmm.2011.05.003
Haqshenas, G. & Doerig, C. Targeting of host cell receptor tyrosine kinases by intracellular pathogens. Sci. Signal. 12, https://doi.org/10.1126/scisignal.aau9894 (2019).
pubmed: 31530732 doi: 10.1126/scisignal.aau9894
Kovacsovics, T. J. et al. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J. Biol. Chem. 270, 11358–11366 (1995).
pubmed: 7744773 doi: 10.1074/jbc.270.19.11358
Scholar, E. M. & Toews, M. L. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett. 87, 159–162 (1994).
pubmed: 7812935 doi: 10.1016/0304-3835(94)90217-8
Liu, Y. et al. Structural basis for selective inhibition of Src family kinases by PP1. Chem. Biol. 6, 671–678 (1999).
pubmed: 10467133 doi: 10.1016/S1074-5521(99)80118-5
Perez, E. A. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol. Cancer Ther. 8, 2086–2095 (2009).
pubmed: 19671735 doi: 10.1158/1535-7163.MCT-09-0366
Zilberman, Y. et al. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J. Cell Sci. 122, 3531–3541 (2009).
pubmed: 19737819 doi: 10.1242/jcs.046813
Hung, C. S., Dodson, K. W. & Hultgren, S. J. A murine model of urinary tract infection. Nat. Protoc. 4, 1230–1243 (2009).
pubmed: 19644462 pmcid: 2963178 doi: 10.1038/nprot.2009.116
Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L. & Hultgren, S. J. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6, e1001042 (2010).
pubmed: 20811584 pmcid: 2930321 doi: 10.1371/journal.ppat.1001042
Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A. & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4, e329 (2007).
pubmed: 18092884 pmcid: 2140087 doi: 10.1371/journal.pmed.0040329
Schaller, G., Lengyel, E., Pantel, K., Hardt, W. & Mischke, D. Keratin expression reveals mosaic differentiation in vaginal epithelium. Am. J. Obstet. Gynecol. 169, 1603–1607 (1993).
pubmed: 7505531 doi: 10.1016/0002-9378(93)90444-N
Box, C. R., Pardoe, J. & Porter Parkinson, J. Discussion on infections of the urinary tract by Bacillus Coli in infancy and childhood. Br. Med. J. 2, 1128–1135 (1910).
Colonne, P. M., Winchell, C. G. & Voth, D. E. Hijacking host cell highways: manipulation of the host actin cytoskeleton by obligate intracellular bacterial pathogens. Front. Cell. Infect. Microbiol. 6, 107 (2016).
pubmed: 27713866 pmcid: 5031698 doi: 10.3389/fcimb.2016.00107
O’Brien, V. P. et al. Low-dose inoculation of Escherichia coli achieves robust vaginal colonization and results in ascending infection accompanied by severe uterine inflammation in mice. PLoS ONE 14, e0219941 (2019).
pubmed: 31329630 pmcid: 6645506 doi: 10.1371/journal.pone.0219941
Nicolle, L. E. et al. Clinical Practice Guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 68, 1611–1615 (2019).
pubmed: 31506700 doi: 10.1093/cid/ciz021
Fichorova, R. N., Rheinwald, J. G. & Anderson, D. J. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 57, 847–855 (1997).
pubmed: 9314589 doi: 10.1095/biolreprod57.4.847
Gilbert, N. M., Lewis, W. G. & Lewis, A. L. Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS ONE 8, e59539 (2013).
pubmed: 23527214 pmcid: 3602284 doi: 10.1371/journal.pone.0059539
Meysick, K. C. & Garber, G. E. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model. J. Parasitol. 78, 157–160 (1992).
pubmed: 1310732 doi: 10.2307/3283708
Patras, K. A. & Doran, K. S. A murine model of Group B streptococcus vaginal colonization. J. Vis. Exp. 117, 54708 (2016).
Watson, M. E., Nielsen, H. V., Hultgren, S. J. & Caparon, M. G. Murine vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes. Infect. Immun. 81, 1606–1617 (2013).
pubmed: 23460515 pmcid: 3648019 doi: 10.1128/IAI.00021-13
Floyd, K. A. et al. Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. PLoS Pathog. 11, e1004697 (2015).
pubmed: 25738819 pmcid: 4349694 doi: 10.1371/journal.ppat.1004697
Cato, E. P., Moore, W. E. C. & Johnson, J. L. Synonymy of strains of “Lactobacillus acidophilus” Group A2 (Johnson et 81. 1980) with the Type Strain of Lactobacillus crispatus (Brygoo and Aladame 1953) Moore and Holdeman 1970. Int. J. Syst. Bacteriol. 33, 426–428 (1983).
doi: 10.1099/00207713-33-2-426

Auteurs

John R Brannon (JR)

Department of Pathology, Microbiology and Immunology, Division of Molecular Pathogenesis, Nashville, TN, USA. john.r.brannon@vumc.org.

Taryn L Dunigan (TL)

Department of Pathology, Microbiology and Immunology, Division of Molecular Pathogenesis, Nashville, TN, USA.

Connor J Beebout (CJ)

Department of Pathology, Microbiology and Immunology, Division of Molecular Pathogenesis, Nashville, TN, USA.

Tamia Ross (T)

Department of Pathology, Microbiology and Immunology, Division of Molecular Pathogenesis, Nashville, TN, USA.

Michelle A Wiebe (MA)

Department of Pathology, Microbiology and Immunology, Division of Molecular Pathogenesis, Nashville, TN, USA.

William S Reynolds (WS)

Department of Urology, Nashville, TN, USA.

Maria Hadjifrangiskou (M)

Department of Pathology, Microbiology and Immunology, Division of Molecular Pathogenesis, Nashville, TN, USA. maria.hadjifrangiskou@vumc.org.
Department of Urology, Nashville, TN, USA. maria.hadjifrangiskou@vumc.org.
Vanderbilt Institute for Infection, Immunology & Inflammation, Vanderbilt University Medical Center, Nashville, TN, USA. maria.hadjifrangiskou@vumc.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH